Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
457.6 GBX | +0.22% | -5.65% | -6.04% |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
Apr. 19 | Peel Hunt starts NatWest and Barclays at 'buy' | AN |
Sales 2024 * | 1.83B 2.33B | Sales 2025 * | 1.97B 2.51B | Capitalization | 1.44B 1.83B |
---|---|---|---|---|---|
Net income 2024 * | 61M 77.72M | Net income 2025 * | 88M 112M | EV / Sales 2024 * | 0.78 x |
Net cash position 2024 * | 9.94M 12.67M | Net cash position 2025 * | 15.56M 19.83M | EV / Sales 2025 * | 0.72 x |
P/E ratio 2024 * |
23.2
x | P/E ratio 2025 * |
15.6
x | Employees | 7,859 |
Yield 2024 * |
5.24% | Yield 2025 * |
6.22% | Free-Float | 94.58% |
Latest transcript on PageGroup plc
1 day | +0.22% | ||
1 week | -5.65% | ||
1 month | +2.55% | ||
3 months | +1.15% | ||
6 months | +2.42% | ||
Current year | -6.04% |
Managers | Title | Age | Since |
---|---|---|---|
Nicholas Kirk
CEO | Chief Executive Officer | - | 22-12-31 |
Director of Finance/CFO | 52 | 06-06-30 | |
Kaye Maguire
LAW | General Counsel | - | 18-09-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marie Metayer
BRD | Director/Board Member | 64 | 17-08-31 |
Director of Finance/CFO | 52 | 06-06-30 | |
Karen Geary
BRD | Director/Board Member | - | 22-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 746 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - | |
0.00% | 45 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 457.6 | +0.22% | 1,119,299 |
24-05-30 | 456.6 | -0.52% | 702,893 |
24-05-29 | 459 | -1.29% | 187,400 |
24-05-28 | 465 | -4.12% | 306,999 |
24-05-24 | 485 | +0.33% | 596,520 |
Delayed Quote London S.E., May 31, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.04% | 1.83B | |
+11.10% | 3.44B | |
+16.09% | 694M |
- Stock Market
- Equities
- MPI Stock